CoChat
Sign Up
Cited by 539Lipoproteins and Cardiovascular HealthAdipokines, Inflammation, and Metabolic DiseasesInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects

Tracy, Russell P., Psaty, Bruce M., Macy, Elizabeth, Bovill, Edwin G., Cushman, Mary, Cornell, Elaine S., Kuller, Lewis H.·1997·Arteriosclerosis, Thrombosis, and Vascular Biology
DOI 10.1161/01.atv.17.10.2167
Open this paper in CoChat — free account

Abstract

Abstract Blood levels of C-reactive protein (CRP), a marker of inflammation, are related to cardiovascular disease risk. To determine cross-sectional correlates in the elderly, we measured CRP in 400 men and women older than 65 years and free of clinical cardiovascular disease at baseline as part of the Cardiovascular Health Study. Only 2% of the values were greater than 10 mg/L, the cut-point usually used to identify inflammation. CRP levels appeared tightly regulated, since there were strong bivariate correlations between CRP and the following: inflammation-sensitive proteins such as fibrinogen ( r =.52); measures of fibrinolysis such as plasmin-antiplasmin complex ( r =.23); pack-years of smoking ( r =.30); and body mass index ( r =.24; all P values≤.001). The association with pack-years was independent of the length of time since cessation of smoking. CRP levels were also associated with coagulation factors VIIc, IXc, and Xc; HDL cholesterol (negative) and triglyceride; diabetes status; diuretic use; ECG abnormalities; and level of exercise. Because of effect modification, two multiple linear regression prediction models were developed for CRP, one each for never smokers and ever smokers. An a priori physiologic model was used to guide these analyses, which disallowed the use of other inflammation-sensitive variables such as fibrinogen. In never smokers, the independent predictors were body mass index (+), diabetes status (+), plasmin-antiplasmin complex (+), and the presence of ECG abnormalities (+); this model predicted 15% of the CRP population variance. In ever smokers, the predictors were body mass index (+), plasmin-antiplasmin complex (+), pack-years of smoking (+), HDL cholesterol (−), and ankle-arm blood pressure index (−); this model predicted 42% of the population variance. We conclude that levels of CRP in the healthy elderly are tightly regulated and reflect lifetime exposure to smoking as well as level of obesity, ongoing level of fibrinolysis, diabetes status, and level of subclinical atherothrombotic disease. Moreover, exposure to smoking affects the relation of CRP to these other factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.17.10.2167

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 17

  1. 1988, Lab Invest., 58, 249
  2. 10.1161/circ.88.2.8339440 · DOI
  3. 10.1182/blood.V76.10.1903.1903 · DOI
  4. 1996, Circulation., 93, 622
  5. 10.1161/circ.88.3.8353913 · DOI
  6. 10.1161/str.22.9.1926258 · DOI
  7. 10.1161/circ.21.6.1160 · DOI
  8. 1994, Arch Pathol Lab Med., 118, 1106
  9. 1993, Arch Path Lab Med., 117, 67
  10. Tracy R Bovill E. Methods for determining fibrinopeptide A. In: Beutler E Lichtman M Coller B Kipps T eds. Williams Hematology. New York NY: McGraw Hill; 1995:L96.
  11. 10.1161/atvb.16.9.1163 · DOI
  12. 10.1161/atvb.15.9.1269 · DOI
  13. 10.1161/atvb.17.6.1121 · DOI
  14. 1996, Circulation., 93, 622
  15. 1995, Circulation., 93, 672
  16. 10.1161/circ.92.7.1693 · DOI
  17. 1993, Am Rev Respir Dis., 47, 125

Cited by

Sorted by citations

Items 501–538 of 538

Related

See all

Metadata

Authors
Tracy, R. P., Psaty, B. M., Macy, E., Bovill, E. G., Cushman, M., Cornell, E. S., & Kuller, L. H.
Affiliations
University of Vermont (US)
ORCID
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1997-10
Volume
17
Issue
10
Pages
2167-2176
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
DOI
10.1161/01.atv.17.10.2167
OpenAlex
W2070195189
Cited by
539
References
56
Citations by year
2026: 3 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 9 · 2021: 6 · 2020: 15 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 14 · 2015: 14 · 2014: 19 · 2013: 15 · 2012: 24
FWCI
13.82
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wake Forest University
  • Johns Hopkins University
  • National Institutes of Health (n01hc085079-024, n01hc085080-026)
  • Genentech
  • University of California, Davis
  • Claude Pepper Older Americans Independence Center, Wake Forest School of Medicine
  • National Heart, Lung, and Blood Institute (R01HL046696, R01-HL-46696, N01HC85080, N01-HC85079)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
C-reactive protein, smoking, pack-years, cardiovascular risk factors, inflammation, fibrinogen, plasmin-antiplasmin complex, fibrinolysis, body mass index, obesity, diabetes mellitus, HDL cholesterol, triglycerides, electrocardiographic abnormalities, older adults, Cardiovascular Health Study, effect modification
MeSH terms
Aged, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Male, Risk Factors, Smoking, Body Mass Index, Multivariate Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review